LOVENOX (PRESERVATIVE FREE) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lovenox (preservative Free), and what generic alternatives are available?
Lovenox (preservative Free) is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in LOVENOX (PRESERVATIVE FREE) is enoxaparin sodium. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lovenox (preservative Free)
A generic version of LOVENOX (PRESERVATIVE FREE) was approved as enoxaparin sodium by SANDOZ INC on November 28th, 2011.
Summary for LOVENOX (PRESERVATIVE FREE)
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 25 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LOVENOX (PRESERVATIVE FREE) at DailyMed |
Pharmacology for LOVENOX (PRESERVATIVE FREE)
Drug Class | Low Molecular Weight Heparin |
Anatomical Therapeutic Chemical (ATC) Classes for LOVENOX (PRESERVATIVE FREE)
Paragraph IV (Patent) Challenges for LOVENOX (PRESERVATIVE FREE)
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LOVENOX (PRESERVATIVE FREE) | Injection | enoxaparin sodium | 100 mg/mL, 3 mL vials | 020164 | 1 | 2006-12-07 |
US Patents and Regulatory Information for LOVENOX (PRESERVATIVE FREE)
Expired US Patents for LOVENOX (PRESERVATIVE FREE)
EU/EMA Drug Approvals for LOVENOX (PRESERVATIVE FREE)
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Techdow Pharma Netherlands B.V. | Inhixa | enoxaparin sodium | EMEA/H/C/004264 Inhixa is indicated for adults for:Prophylaxis of venous thromboembolism, particularly in patients undergoing orthopaedic, general or oncological surgery.Prophylaxis of venous thromboembolism in patients bedridden due to acute illnesses including acute heart failure, acute respiratory failure, severe infections, as well as exacerbation of rheumatic diseases causing immobilisation of the patient (applies to strengths of 40 mg/0.4 mL).Treatment of deep vein thrombosis (DVT), complicated or uncomplicated by pulmonary embolism.Treatment of unstable angina and non Q wave myocardial infarction, in combination with acetylsalicylic acid (ASA).Treatment of acute ST segment elevation myocardial infarction (STEMI) including patients who will be treated conservatively or who will later undergo percutaneous coronary angioplasty (applies to strengths of 60 mg/0.6 mL, 80 mg/0.8 mL, and 100 mg/1 mL).Blood clot prevention in the extracorporeal circulation during haemodialysis. |
Authorised | no | yes | no | 2016-09-15 | |
Pharmathen S.A. | Thorinane | enoxaparin sodium | EMEA/H/C/003795 Thorinane is indicated for adults for:, , - Prophylaxis of venous thromboembolism, particularly in patients undergoing orthopaedic, general or oncological surgery., , - Prophylaxis of venous thromboembolism in patients bedridden due to acute illnesses including acute heart failure, acute respiratory failure, severe infections, as well as exacerbation of rheumatic diseases causing immobilisation of the patient (applies to strengths of 40 mg/0.4 mL)., , - Treatment of deep vein thrombosis (DVT), complicated or uncomplicated by pulmonary embolism., , - Treatment of unstable angina and non Q wave myocardial infarction, in combination with acetylsalicylic acid (ASA)., , - Treatment of acute ST segment elevation myocardial infarction (STEMI) including patients who will be treated conservatively or who will later undergo percutaneous coronary angioplasty (applies to strengths of 60 mg/0.6 mL, 80 mg/0.8 mL, and 100 mg/1 mL)., , - Blood clot prevention in the extracorporeal circulation during haemodialysis., , Prevention and treatment of various disorders related to blood clots in adults., |
Withdrawn | no | yes | no | 2016-09-14 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for LOVENOX (PRESERVATIVE FREE)
See the table below for patents covering LOVENOX (PRESERVATIVE FREE) around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 9101957 | ⤷ Try a Trial | |
Bosnia and Herzegovina | 97179 | ⤷ Try a Trial | |
Croatia | P970502 | PROCESS FOR PREPARING MUCOPOLYSACCHARIDES HEPARINE DERIVATIVES | ⤷ Try a Trial |
Canada | 2045433 | MELANGES DE POLYSACCHARIDES DE BAS POIDS MOLECULAIRES; PROCEDE DE PREPARATION ET UTILISATION (LOW MOLECULAR WEIGHT POLYSACCHARIDE MIXES; PROCESS FOR THEIRPREPARATION AND USE) | ⤷ Try a Trial |
Mexico | 25829 | MEZCLAS DE POLISACARIDOS SULFATADOS Y PROCEDIMIENTO PARA SU PREPARACION. | ⤷ Try a Trial |
Yugoslavia | 43008 | ⤷ Try a Trial | |
Netherlands | 194947 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |